CompoAtlas

Lipont Melatonin and Magnesium 3/150 mg

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide

Source : Mélatonine

3 mgNot calculated
Magnésium

Source : Citrate de magnésium

150 mg150,000 µg

Non-medicinal ingredients

Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps (to) prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people/if travelling by plane easterly across two or more time zones/flying east over two or more time zones). Helps (to) re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps in the development and maintenance of bones/(and) teeth. Helps to maintain/support heart muscle function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Other names
Melatonin 3 mg + Magnesium 150 mg, Melatonin with Magnesium 3 mg/150 mg, Melatonin with Magnesium SLEEP SUPPORT, Melatonin/Magnesium
Licence holder
Libang Clinical Nutrition (Canada) Ltd.
NPN or DIN-HM
80147000
Status
Active licence
Licence date
20 January 2026
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80147000

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Lipont Melatonin and Magnesium 3/150 mg (Libang Clinical Nutrition (Canada) Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80147000-lipont-melatonin-and-magnesium-3-150-mg, updated 20 January 2026.

Enter to analyse, Shift+Enter for a new line